| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | 0.013 | 0.9 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | serdemetan | FIMM | pan-cancer | AAC | 0.011 | 0.9 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.0026 | 1 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |